New Releases from NCBI BookshelfBeta interferons and glatiramer acetate for treating multiple sclerosis.Beta interferons and glatiramer acetate for treating multiple sclerosis.
Post Content
December 15, 2025
Uncategorized
New Releases from NCBI BookshelfOdevixibat (Bylvay): Indication: For the treatment of cholestatic pruritus in patients aged 12 months and older with Alagille syndrome (ALGS): Reimbursement Recommendation [Internet].Odevixibat (Bylvay): Indication: For the treatment of cholestatic pruritus in patients aged 12 months and older with Alagille syndrome (ALGS): Reimbursement Recommendation [Internet].
Canada’s Drug Agency (CDA-AMC) recommends that Bylvay be reimbursed by public drug plans for the treatment of cholestatic pruritus in
Uncategorized
New Releases from NCBI BookshelfTrabectedin: Therapeutic area: Soft tissue and uterine leiomyosarcoma: Reimbursement Review [Internet].Trabectedin: Therapeutic area: Soft tissue and uterine leiomyosarcoma: Reimbursement Review [Internet].
Soft tissue sarcomas are a heterogeneous group of rare tumours in muscle, adipose, fibrous, cartilage, nerve, and vascular tissue. Leiomyosarcoma
